The plastic nature of the vascular wall: Reply to lee, sandow, and demay

Physiology

Volumn 24, Issue 5, 2009, Pages 273-275

  Martinez Lemus, Luis A ^a   Hill, Michael A ^a   Meininger, Gerald A ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349934528     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00028.2009     Document Type: Letter

References (45)

1. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation: contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 61: 181-186, 1987.
2. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, Vanbavel E. Small artery remodeling depends on tissue-type transglutaminase. Circ Res 96: 119-126, 2005.
3. Bakker EN, Buus CL, VanBavel E, Mulvany MJ. Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling. J Vasc Res 41: 174-182, 2004.
4. Bakker EN, Sorop O, Spaan JA, VanBavel E. Remodeling of resistance arteries in organoid culture is modulated by pressure and pressure pulsation and depends on vasomotion. Am J Physiol Heart Circ Physiol 286: H2052-H2056, 2004.
5. Bakker EN, van Der Meulen ET, Spaan JA, VanBavel E. Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol Heart Circ Physiol 278: H1233-H1240, 2000.
6. Bakker EN, van der Meulen ET, van den Berg BM, Everts V, Spaan JA, VanBavel E. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 39: 12-20, 2002.
7. Baumbach GL, Hajdu MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension 21: 816-826, 1993.
8. Berthoud VM, Minogue PJ, Laing JG, Beyer EC. Pathways for degradation of connexins and gap junctions. Cardiovasc Res 62: 256-267, 2004.
9. Boffa JJ, Tharaux PL, Placier S, Ardaillou R, Dussaule JC, Chatziantoniou C. Angiotensin II activates collagen type I gene in the renal vascu-lature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-medi-ated mechanism. Circulation 100: 1901-1908, 1999.
10. Borisov AB, Huang SK, Carlson BM. Remodeling of the vascular bed and progressive loss of capillaries in denervated skeletal muscle. Anat Rec 258: 292-304, 2000.
11. Bund SJ, Lee RM. Arterial structural changes in hypertension: a consideration of methodology, terminology and functional consequence. J Vasc Res 40: 547-557, 2003.
12. Buus NH, VanBavel E, Mulvany MJ. Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as can-nulated preparations. Br J Pharmacol 112: 579-587, 1994.
13. Choi ET, Khan M F, Leidenfrost JE, Collins E T, Boc K P, Villa BR, Novack DV, Parks WC, Abendschein DR. Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice. Circulation 109: 1564-1569, 2004.
14. Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens 19: 1001-1006, 2001.
15. Daly CJ, Gordon J F, McGrath JC. The use of fluorescent nuclear dyes for the study of blood vessel structure and function: novel applications of existing techniques. J Vasc Res 29: 41-48, 1992.
16. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE, Miclini M, Zani F, Muiesan ML, Donato F, Salvetti M, Castellano M, Tiberio GA, Giulini SM, Agabiti Rosei E. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 20: 846-852, 2007.
17. Dominiczak A F, McLaren Y, Kusel JR, Ball DL, Goodfriend TL, Bohr D F, Reid JL. Lateral diffusion and fatty acid composition in vascular smooth muscle membrane from stroke-prone spontaneously hypertensive rats. Am J Hypertens 6: 1003-1008, 1993.
18. Falloon BJ, Stephens N, Tulip JR, Heagerty AM. Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Physiol Heart Circ Physiol 268: H670-H678, 1995.
19. Girardot D, Demeilliers B, deBlois D, Moreau P. ERK1/2-mediated vasoconstriction normalizes wall stress in small mesenteric arteries during NOS inhibition in vivo. J Cardiovasc Pharmacol 42: 339-347, 2003.
20. Heerkens EH, Shaw L, Ryding A, Brooker G, Mullins JJ, Austin C, Ohanian V, Heagerty AM. AlphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension 47: 281-287, 2006.
21. Hill MA, Potocnik SJ, Martinez-Lemus LA, Meininger GA. Delayed arteriolar relaxation after prolonged agonist exposure: functional remodeling involving tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 285: H849-H856, 2003.
22. Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 33: 569-574, 1999.
23. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 36: 312-318, 2000.
24. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38: 581-587, 2001.
25. Klingelhofer J, Laur OY, Troyanovsky RB, Troyanovsky SM. Dynamic interplay between adhesive and lateral E-cadherin dimers. Mol Cell Biol 22: 7449-7458, 2002.
26. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 22: 523-526, 1993. (Pubitemid 23292158)
27. Martinez-Lemus LA. Persistent agonist-induced vasoconstriction is not required for angiotensin II to mediate inward remodeling of isolated arteri-oles with myogenic tone. J Vasc Res 45: 211-221, 2008.
28. Martinez-Lemus LA, Hill MA, Bolz SS, Pohl U, Meininger GA. Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: implications for functional remodeling. FASEB J 18: 708-710, 2004.
29. Martinez-Lemus LA, Hill MA, Meininger GA. The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arte-riolar diameter and structure. Physiology 24: 45-57, 2009.
30. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder A P, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25: 1021-1026, 2007.
31. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 17: 105-109, 2002.
32. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 70: 921-961, 1990.
33. Mundhenke M, Schwartzkopff B, Strauer BE. Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy. Virchows Arch 431: 265-273, 1997.
34. Novak IL, Slepchenko BM, Mogilner A, Loew LM. Cooperativity between cell contractility and adhesion. Phys Rev Lett 93: 268109, 2004.
35. Porteri E, Rizzoni D, Mulvany MJ, De Ciuceis C, Sleiman I, Boari GE, Castellano M, Muiesan ML, Zani F, Rosei EA. Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. J Hypertens 21: 2345-2352, 2003.
36. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 108: 2230-2235, 2003.
37. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihyper-tensive treatment. Am J Hypertens 17: 1192-1200, 2004.
38. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens 14: 1247-1255, 1996.
39. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 23: 83-91, 1994.
40. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomy-opathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol 31: 1089-1096, 1998.
41. Sonveaux P, Dessy C, Martinive P, Havaux X, Jordan B F, Gallez B, Gregoire V, Balligand JL, Feron O. Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Res 64: 3209-3214, 2004.
42. Sun Z, Martinez-Lemus LA, Hill MA, Meininger G. Extracellular matrix-specific focal adhesions in vascular smooth muscle produce mechanically active adhesion sites. Am J Physiol Cell Physiol 295: C268-C278, 2008.
43. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti A. Endothelium, aging, hypertension. Curr Hypertens Rep 8: 84-89, 2006.
44. Trache A, Meininger GA. Atomic force-multi-optical imaging integrated microscope for monitoring molecular dynamics in live cells. J Biomed Opt 10: 064023, 2005.
45. Zhou MS, Jaimes EA, Raij L. Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J Hypertens 23: 1737-1743, 2005.